Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Method and apparatus for increasing query traffic to a web site
Method and apparatus for focusing electrical stimulation in the brain during electro-convulsive therapy
Composition for enhancing memory and mitigating neurodegeneration and method thereof
Granulated sweetening composition
System and method for multi-threaded MIMO OFDM channel equalizer
Mobile interactive kiosk method
Ice data collection system
  Randomly Featured Patents
Dehydrogenation of alcohols
Method for producing 4-hydroxybutyl (meth)acrylate
Packet-parallel high performance cryptography systems and methods
Simplified onboard attitude control based on star sensing
Gallium nitride group compound semiconductor light-emitting device
Rotary end face seal assembly
Antiseptic mask and method of using antiseptic mask
Method of and apparatus for convoluting bands around rod-shaped articles
Catheter with angled tip of reduced diameter
Ball formation method